Abstract. It has been suggested that pit-1 protein may play a role in the differentiation of the anterior pituitary cells. The present Immunohistochemical studies were designed to elucidate the relationship between functional differentiation of pituitary adenoma and expression of pit-1 protein in human (h) GRF transgenic mice. Pituitaries from a 10 month old and a 6 month old transgenic mice were fixed in 4% paraformaldehyde and embedded in paraffin. The indirect immunoperoxidase method was performed using antibodies against hGRF, GH, PRL, ACTH, a subunit (SU), FSH/3 SU, LH/3 SU, TSH SU, and pit-1 protein. Immunohistochemical double staining was performed at light and electron microscopic levels. The pituitary glands of hGRF transgenic mice (both 10 month and 6 month old) demonstrated diffuse hyperplasia of GH positive cells with coexpression of hGRF within the same cells. There were also scattered cells which were positive for other hormones and hormone subunits in the hyperplastic pituitary. Three discrete nodules were found in the pituitary gland of a 10 month old hGRF transgenic mouse and were identified as adenomas. These adenomas were composed of enlarged round cells which were positive only for GH, hGRF, PRL and TSH/3 SU. Pit-1 protein was intensely expressed in the nuclei of the adenoma cells. These results suggest the existence of an autocrine mechanism by hGRF in the formation of somato-lacto-thyrotroph adenoma via constitutive pit-1 expression.
IT HAS BEEN reported that the pituitary specific transcription factor (pit-1) gene produces nucleus binding protein composed of 291 amino acids. This protein has been especially interested by various investigators because it contains 60 amino acids near the C-terminus which are homologous to those of homeodomein in Dorosophilia [1] . The homeodomain (POU domain) is known to work in Dorsophilia as a promoting factor for their development.
Simmons et al. [2] recently reported that in developing rat pituitary glands, pit-1 mRNA is distributed in all anterior cells, but that pit-1 protein is expressed in certain cells only, that is, GH, PRL and TSH cells. Human and mouse dwarfs with a mutation of the pit-1 gene have been reported to be deficient in GH, PRL and TSH secretion [3, 4, 5] .
On the other hand, human GRF transgenic mice have been reported to produce a pituitary tumor OSAMURA et al. which is immunologically positive for human GRF and GH [6, 7] . Northern blot analysis has disclosed expression of hGRF mRNA not only in the pituitary glands but also in the liver, pancreas and gut etc. [6] . Human (h)GRF transgenic mice with expressions of hGRF in various organs have been reported previously [6] . We utilized the pituitary glands from 6 and 10 month old male hGRF transgenic mice with metallothionein I promotor (one animal for each age) originated from strains established by Mayo et al. [6] .
Immunohistochemical studies were done on the tissue fixed by 4% paraformaldehyde and embedded in paraffin. The indirect peroxidase method was performed by the antibodies against hormones (Table 1 ) and against pit-1 protein [2] .
Immunoelectron microscopy (post-embedding methods) was performed on ultrathin sections using antibodies against GH and PRL. In brief, the tissue was fixed in 4% paraformaldehyde and embedded in LR-White plastic. Ultrathin sections were reacted with the antibodies shown above and protein A gold with gold particles of different diameters at 10 and 20 urn. For double labeling, two different antibodies were reacted on opposite surfaces of the ultrathin sections [8] . Serum hGRF, GH levels were measured by the sensitive sandwich enzyme immunoassay [9] .
Results
The serum levels of GRF and GH were clearly elevated in a 6 month-and a 10 month-old transgenic mice compared with those of the control non-transgenic mice. Serum GRF and GH were 100 ng/ml and 800 ng/ml, respectively, in a 10 month transgenic mice, and those in a 6 month old mouse were 34 ng/ml and 19 ng/ml, respectively. The pituitary glands were slightly (in a 6 month old transgenic mouse) or markedly (in a 10 month old transgenic mouse) enlarged in the transgenic mice (Fig. 1) .
The pituitary gland in a 10 month old transgenic mouse showed diffuse hyperplasia and three well demarcated nodular lesions (Figs. 1 and 2), whereas a 6 month old transgenic mouse revealed only hyperplastic anterior pituitary cells without nodules. The nodular lesions in a 10 month old hGRF transgenic mouse were composed of larger, less eosinophilic and more monotonous cells. Immunohistochemically, pituitary cells in both hyperplasia and in nodular lesions expressed hGRF and GH (Fig. 3) . Many cells were also positive for PRL. In the hyperplasia, there were also scattered cells positive for ACTH, a SU, and TSH/3 SU besides GH and/or PRL positive cell. In the nodular lesions, however, only GH, PRL and TSH/3 SU were demonstrated immunohistochemically (Table 2, Fig. 3 ). These nodular lesions showing monotonous proliferation of pituitary cells, together with characteristic hormonal expression by immunohistochemistry, were interpreted as adenomas.
Immunoelectron microscopically, by double labeling methods, the same secretory granules in the adenoma cells contained both GH and PRL (Fig. 4) .
Pit-1 protein was immunohistochemically demonstrated in pituitary cells not only in adenomas but also in hyperplastic areas. Pit-1 protein was immunohistochemically specifically localized in the nuclei. The immunohistochemical expression of pit-1 protein was more prominent in the adenoma and three nodules. The cellular component of the latter was more monotonus than that of hyerplastic areas and showed immunohistochemical diffuse staining for hGRF, GH, PRL and TSH/3 SU, but negative for a SU, ACTH, FSH/3, and LH/3. From these findings, the nodules were interpreted as adenomas. Coexpression of GH and hGRF suggested the autocrine mechanism involved in the development of these hyperplastic and adenomatous lesions.
These adenoma cells were considered to be able to be a model of human GH secreting adenomas [10] . Electron microscopic colocalization of GH and PRL in the same secretory granules, which was observed in the adenoma cells in our studies, has been reported in the human pituitary somatomammotrophic adenomas [11, 12] . Specific expression of TSH/3 SU in the adenomas was noteworthy, because in human GH secreting adenomas, besides frequent immunohistochemical ex- pression of GH, PRL, and a SU it has been reported that some of these GH secreting adenoma cells were also positive for TSH/3 SU [10]. Simmons et al. reported the presence of pit-1 protein in GH, PRL and TSH producing cells of the developing and adult rat pituitary glands [2] . The adenomas in our transgenic mouse also showed positive cells for GH, PRL, and TSH/3 SU as mentioned above. Immunohistochemically, pit-1 protein was localized in the nuclei of increased pituitary cells both in hyperplasia and adenomatous lesions. The staining intensity was more prominent in the adenoma cells. These results suggest that pit-1 protein may play major roles in the functional differentiation of the anterior pituitary of hGRF transgenic mice and especially in the functional differentiation of the adenomas. That is, pit-1, together with neoplastic transformation of the autocrine-stimulated pituitary cells, entertained more specific roles in functional differentiation toward GH, PRL, and TSHI3 SU production.
In summary, in long lived (10 months) hGRF transgenic mice, autocrine mechanisms of hGRF and pit-1 protein were suggested to play roles in both in the development and functional differentiation of the adenomas.
